Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
Font Down Font Up

 
Abercrombie & Fitch Oct. Comps Down 15% - Update
11/5/2009 11:59 AM  ET

RELATED NEWS
Abercrombie & Fitch Closed At New High For Year Friday
Raising Target, Estimates On Abercrombie & Fitch - FBR Capital Markets Comments
Abercrombie & Fitch Surged To A New High On Q3 Earnings News
Abercrombie & Fitch Q3 Profit Falls On Lower Comps, Yet Tops View - Update
Abercrombie & Fitch Q3 Profit Declines - Quick Facts
TOP MARKET NEWS
Stocks Close Mostly Lower Amid Disappointing Quarterly Results - U.S. Commentary
Stocks Remain Stuck In The Red In Mid-Afternoon Trading - U.S Commentary
Stocks Posting Moderate Losses In Early Afternoon Trading - U.S. Commentary
New Guidelines Recommend Women Wait Until 21 For Cervical Cancer Screening
Stocks Seeing Further Downside In Late Morning Trading - U.S. Commentary
(RTTNews) -  Casual apparel retailer Abercrombie & Fitch Co. (ANF: News ) Thursday reported a 15% decline in comparable store sales for October, as well as a 5% decline in net sales during the period. In comparison to the preceding two periods, Abercrombie & Fitch's comparable store sales fared much better in October.

The New Albany, Ohio headquartered company that owns Abercrombie & Fitch, abercrombie, Hollister and RUEHL brands, reported October net sales of $203.4 million, a 5% decline when compared to $215.0 million recorded in the same period a year ago.

Total company direct-to-consumer net merchandise sales increased 24% to $22.0 million.

For September 2009, the company reported an 18% decline in comparable store sales, while net sales declined 10% to $248.2 million. The company's comparable sales for August 2009 declined 29%, while net sales declined 23% to $313.9 million.

Brand-wise in October, Abercrombie & Fitch comparable store sales decreased 8% and abercrombie comparable store sales decreased 17%. Hollister Co. October comparable store sales decreased 21% and RUEHL comparable store sales decreased 23%.

Quarter-to-date, the company reported a 22% decline in comparable store sales and a 11% decline in total company direct-to-consumer net merchandise sales at $63.9 million. Net sales for the quarter-to-date period declined 15% to $765.5 million from $896.3 million last year.
For the preceding second quarter of 2009, the company's net sales declined 5% to $657.60 million from $688.82 million in the prior year quarter. Comparable store sales decreased 10% for the quarter, compared to a 9% decline last year.

Comparable store sales for the year-to-date period ended October 31, 2009 decreased 27%. Total company direct-to-consumer net merchandise sales decreased 8% to $161.6 million. Year-to-date net sales were $2.026 billion, down 20% from $2.542 billion a year ago.

In the previous year-to-date period ended September 2009, the company's net sales decreased 22% to $1.823 billion from $2.327 billion in the same period last year. Comparable store sales for the period declined 28% from the year-ago period, while total company direct-to-consumer net merchandise sales decreased 12% year-over-year to $139.6 million.

At month end, the company operated 347 Abercrombie & Fitch stores, 209 abercrombie stores, 509 Hollister Co. stores, 27 RUEHL stores and 16 Gilly Hicks stores in the United States. The company also operated three Abercrombie & Fitch stores, three abercrombie stores and six Hollister Co. stores in Canada, one Abercrombie & Fitch store and seven Hollister Co. stores in the United Kingdom, and one Abercrombie & Fitch store and one abercrombie store in Italy. The company operates e-commerce websites as well.

To receive FREE breaking news email alerts for Abercrombie & Fitch Co. and others in your portfolio


 1   2   Next Page 


Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print        

     
  Trading Center
 

More Breaking News-US

127  Indian Appointed To Key IMF Post
126  FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With Autistic Disorder - Update
125  EU Extends Review Deadline For Oracle's Proposed Takeover Of Sun Micro - Update
124  Pfizer's Geodon Approved As Adjunctive For Bipolar Disorder - Update
123  CF Nominees Enter Terra's Board - Update
122  Archipelago Learning Prices IPO Within Expected Range; Stock Soars - Update
121  Brown University And IBM Launch Multimillion-Dollar Supercomputer - Update
120  GLG Life Tech Starts Trading On Nasdaq; Shares Down 13.7% - Update
119  Global Defense Technology Prices IPO At $13/Share, Below Prior Estimate - Update
118  Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update
117  Covidien's Pain Drug NDA Review Extended By FDA - Update
116  Inovio's Pre-clinincal Study Of Universal Flu Vaccines Reports Protective Response Against Multiple Influenza Strains; Stock Up - Update
115  Cloud Peak Energy Prices IPO At $15/shr - Update
114  Met-Pro Q3 Profit Plunges - Update
113  Boston Scientific Receives FDA's 510 (k)Clearance For WallFlex Fully Covered Esophageal Stent - Update
  

 

Copyright © 2009 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service | How To Use RTTNews.com| Advertise| Buy Content | RSS